SUMMARY To investigate the effect on blood pressure of a modest increase in dietary potassium intake, 38 healthy, free-living families were enrolled in a study involving 4 weeks of potassium supplementation. This was preceded by collection of five baseline measurements of blood pressure and urinary electrolyte excretion and followed by a 4-week recovery period. Although there was a significant increase in urinary potassium excretion during supplementation in both adults and children (p<0.001), there were no significant changes in systolic, diastolic, or mean arterial blood pressure. Height and weight increased significantly in children (p< 0.001), and weight increased in adults (p<0.01) over the course of the study. Multivariate analysis of variance of blood pressure controlling for these confounding variables failed to reveal any effect of the potassium supplementation on blood pressure. These results suggest that increasing intake of dietary potassium alone in a healthy, freeliving normotensive population is unlikely to have a discernible effect on blood pressure. with the primary focus on electrolyte intake, particularly sodium and potassium. It has been hypothesized that diets relatively high in sodium and low in potassium are an important contributing factor 2 in the pathogenesis of this disease. Although dietary sodium has been studied extensively in both hypertensive 3 " 7 and normotensive 8 adults, potassium has received much less attention. Studies of potassium supplementation in hypertensive subjects have produced conflicting results.
T HE issue of diet in the development of hypertension has received considerable attention,' with the primary focus on electrolyte intake, particularly sodium and potassium. It has been hypothesized that diets relatively high in sodium and low in potassium are an important contributing factor 2 in the pathogenesis of this disease. Although dietary sodium has been studied extensively in both hypertensive 3 " 7 and normotensive 8 adults, potassium has received much less attention. Studies of potassium supplementation in hypertensive subjects have produced conflicting results. 9 ' 10 Animal studies, which have been reviewed in detail elsewhere," indicate that potassium supplementation produces a moderate blood pressure decrease in some hypertensive animal models but has little effect in normotensive animals.
438
HYPERTENSION VOL 10, No 4, OCTOBER 1987 digital scale (Hanson Memorie; Hanson Scale, Schubuta, MS, USA). The children's height was measured in the same location in the home on a monthly basis. Baseline data involved the collection of five 24-hour urine samples and concomitant blood pressure measurements over a 1-month period. The average of the last two of three blood pressure measurements was used for data analysis. Diastolic blood pressure was recorded as Phase V of the arterial pressure. Zero recordings for children were excluded from analysis. These five blood pressure, weight, and 24-hour urinary sodium, potassium, and creatinine determinations form the control data against which subsequent determinations were compared.
After collection of baseline information, parents and twins received a medical history and physical examination by a physician-investigator before the initiation of potassium supplementation. No participants were ruled ineligible because of health problems. Elevated blood pressure was not a criterion for exclusion from participation; three parents who reported receiving antihypertensive medications were excluded from these analyses. There were no other hypertensive subjects, so the analyses are limited to normotensive subjects.
In each family, both parents and one twin were given a non-chloride-containing liquid potassium supplement (Twin-K; Boots Pharmaceuticals, Shreveport, LA, USA). The potassium in this supplement is provided in the form of potassium gluconate and potassium citrate. The second twin received a non-potassium-containing placebo liquid identical in all respects to the potassium supplement provided by Boots Pharmaceuticals. Subjects were aware of their treatment assignment. Although the liquid form is less precise in dosage form (i.e., dosage prescribed in common household measures), it produced less gastrointestinal side effects and was more acceptable to children than solid potassium preparations. Unfortunately, use of the liquid dosage form precluded any objective estimate of compliance such as pill counts. No major adverse effects were encountered, although transient nausea was reported by some volunteers on initiation of supplementation that subsided after a few days. The amount of potassium supplementation was based on the average potassium excretion during baseline and was designed to double baseline dietary potassium intake. Participants were specifically instructed not to alter their diet in any way during the study. This regimen resulted in a modest increase in ingested potassium. All subjects took the supplement for 4 weeks followed by a 4-week period of recovery. Men were prescribed an average supplement of 66.0 ± 19.9 (SD) mEq/day. The average prescribed supplement was 53.7 ± 13.6 mEq/day for women, 45.0 ± 17.4 mEq/ day for boys, and 36.2 ± 12.8 mEq/day for girls. Parents collected 24-hour urine samples every other week, and twins collected samples weekly.
Urine samples were analyzed for sodium, potassium, and creatinine using standard flame photometry and autoanalyzer techniques. A urine sample was considered representative if the creatinine excretion was ± 20% of the mean creatinine content of all complete baseline collections for that individual. Overall, 19.7% of urine collections were determined to be incomplete according to these criteria. Incomplete urine collections were excluded from analyses to avoid any bias caused by systematic undercollection.
Data base management was accomplished by Model 204 on the IBM 4381 (Armonk, NY, USA) for ease in handling missing or incomplete data.
n For these analyses, retrieval involved the average of all complete data for a given variable at baseline, during potassium supplementation, and during the recovery period. The analyses were performed on this average value. Statistical analyses, including repeated-measures analysis of variance, Pearson correlation coefficients, and paired t tests, were performed using SPSSX. 13 Values are given as means ± SD.
Results
All participants were white. Volunteers participated as a family unit, and no other dietary modifications were imposed. Recruitment of families was staggered over a 3-year period to avoid any systematic bias caused by seasonal food preferences. A total of 38 families participated in this investigation.
The average age of the adults was 42.0 ± 8.4 years, while that of the children was 11.6 ±3.8 years. In general, men (age, 44.0 ± 6.6 years) were slightly older than women (age, 40.3 ±9.4 years), whereas boys (age, 11.4 ± 3.8 years) and girls (age, 11.7 ± 3.8 years) were of comparable ages. Table 1 presents the results of the repeated-measures analysis of variance for the adults, as a group and for women and men separately. As can be seen, the supplementation resulted in an increased potassium excretion during the 4-weekperiod (81.6 ±33.5 vs58.6± 17.1 mEq/day for control or 56.7 ± 18.6 mEq/day for recovery periods). Sodium excretion was not significantly different under the three conditions. These results are also reflected in the sodium/potassium ratio. Table 2 presents the results for the children. Once again, the supplement resulted in higher excretion of potassium (48.6 ±23.2 mEq/day) when compared with baseline (37.1 ± 15.1 mEq/day) or recovery periods (36.8 ±14.8 mEq/day). The increases in height and weight over the course of the study were expected in growing children. As in the adults, no significant changes in blood pressure were attributable to the intervention in this population. For comparison purposes, Table 3 shows the data for the placebo-treated children. There were no temporal trends in blood pressure or sodium excretion in any comparisons. There was a slight downward trend in potassium excretion for the group as a whole, which was significant only in repeated-measures analysis, during supplementation, but not in paired comparisons between adjacent conditions. Paired comparisons of these variables between members of a twin pair showed that the only significant difference was for potassium excretion during the supplementation period.
In adults, the change in systolic blood pressure (from baseline to supplementation period) was correlated with the increase in weight (r = 0.24, p<0.05), but this association was not seen in diastolic or mean arterial blood pressure. This same result was found in children (r = 0.27, p<0.05). Also for children, there was a positive correlation between the change in height and both diastolic (r = 0.33, p<0.05) and mean arterial (r = 0.32, p<0.05) pressures. Age was correlated with blood pressure in these populations (adult: systolic, r = 0.42, /><0.001; diastolic, r = 0.36, /?<0.01; and mean, r = 0.42, /?<0.001); children: systolic, r = 0.51, p<0.001; diastolic, r = 0.42, p<0.0\; and mean, r = 0.49, p<0.001). Therefore, a multivariate analysis of variance of blood pressure variables using these factors as covariates was performed. Even after controlling for the potential confounding effects of these variables, no significant effect of intervention on blood pressure was discernible.
Comparisons between the potassium-supplemented and the placebo-treated control twins showed that, although potassium excretion was significantly higher in the treated twin (p<0.001), there were no significant differences between the twins in blood pressure or sodium excretion. The urinary sodium/potassium ratio was also significantly lower in the supplemented compared with the control twin (2.32 ±0.12 vs 3.17 ± 0.16; p<0.001) during the supplementation period. No relationship was seen between sodium/potassium ratio and blood pressure before, during, or after potassium supplementation.
Discussion
The issue of the role of dietary electrolytes in the development of hypertension has been the subject of much scientific debate.'-2 -"• ' 4 Horan et al." recently reviewed the subject of diet and hypertension, emphasizing the unanswered questions and outlining areas of interest, particularly the effects of dietary modifications and the differential effects of sodium and potassium on children and normotensive persons. The present study was designed to expand previous studies of dietary modification and blood pressure, which had been limited to sodium restriction in normotensive adults and children. ' *• " Our earlier studies had demonstrated that the change in blood pressure in response to dietary sodium reduction occurred during the initial 2 weeks of the intervention. On the basis of this experience, we felt that a 4-week period of potassium supplementation should be adequate to detect a change in blood pressure.
Previous studies in normotensive adults also failed to demonstrate a significant blood pressure decrease in response to potassium supplementation. 18 -" However, one study of young men did report a significantly lower diastolic blood pressure during potassium supplementation. 20 Recently, the contribution of the chloride ion to the development of hypertension has been the subject of considerable discussion. 21 "" These studies and others 24 used potassium chloride as the vehicle for increasing potassium intake. To avoid the potential negating effect of the chloride ion, we chose a supple-ment form that was a combination of potassium gluconate and potassium citrate. This change resulted in only a modest increase in urinary excretion. In addition, we thought that this supplement would more likely mimic natural dietary potassium sources.
The results of our study (see Tables 1 and 2 ) are consistent with the conclusion that alterations in dietary potassium, independent of changes in sodium intake, do not produce significant reduction in the blood pressures of white normotensive adults and children. Although the potassium excretion did not double, this finding is not surprising, since at least one study with a documented increase in dietary potassium intake from food failed to produce a significant increase in excretion. 25 In a study in which similar potassium supplements were administered in a supervised environment, ensuring compliance, urinary potassium excretion during a sodium intake of 200 mEq/day reflected less than half on the average of the potassium administered. 26 Studies using potassium chloride as a supplement for subjects on an ad libitum sodium intake have also demonstrated that the magnitude of the increase in potassium intake was not reflected in the magnitude of the increase in excretion. 20 -26 In this study, as in our previous study of sodium restriction, 16 the change in blood pressure in children was highly correlated with growth. This finding is consistent with previous investigations showing that body size and growth are the major determinants of blood pressure in children. 28 -29 However, analyses controlling for these factors still failed to produce any significant effect of the intervention on blood pressure.
Our findings are in contrast to studies of potassium supplementation in hypertensive subjects.
9 -M - 31 In these studies, however, potassium supplementation appeared to be correcting a deficiency, consistent with findings of studies using potassium in rat models of hypertension." Correction of hypokalemia may be clinically beneficial in the treatment of hypertension. 30 Some studies of potassium supplementation in hypertensive subjects have also failed to produce a blood pressure-lowering effect. 10 - 2732 Treasure and Ploth   33 have recently reviewed the extensive literature regarding potential mechanisms whereby potassium could reduce blood pressure. These authors suggest that inconsistencies in the effects of potassium may be due to the fact that it is effective only in subgroups of susceptible individuals or in sodium-dependent forms of hypertension. Some investigators have suggested that the relative deficiency of potassium in the typical American diet in comparison to sodium may exert a permissive effect in increasing blood pressure in susceptible persons. We examined the possibility that the sodium/potassium ratio, which we modified during the period of potassium supplementation, might be more reflective of the effect of potassium than of sodium on blood pressure. We were unable to observe a correlation between this ratio and blood pressure during baseline, supplementation, or recovery periods in these healthy, normotensive white adults and children.
The study design employed the comparison of monozygotic twins. By taking advantage of the unique genetic and environmental controls inherent in this study design, one can increase the efficiency and detect small differences in response 34 ; the application of the twin model to scientific questions of this nature has been recommended. 35 Calculations of the relative efficiency indicated that at least three times more unrelated children would have been required to achieve a similar degree of significance in comparisons of the electrolyte excretion (relative efficiency: potassium, 314%; sodium, 349%; sodium/potassium, 275%). In contrast, the relative efficiency was even greater for the blood pressure variables (systolic, 836%; diastolic, 900%). Using the information from the twin comparisons, we can estimate the sample size required to detect a significant blood pressure difference with a 90% power and an a level of 0.05. For systolic blood pressure, this estimate exceeded 1000 children per group. When data from the differences between members of a twin pair were used and an a value of 0.05 and a power of 90% were assumed, this study was able to detect a difference of 3.2 mm Hg in systolic and 3.3 mm Hg in diastolic pressure in the twin children. For adults, simple power calculations indicated that with an a value of 0.05 we had a 90% chance of detecting a difference of 3.2 mm Hg in systolic blood pressure. The changes for diastolic pressure and mean arterial pressure were positive and thus preclude power calculations. These results give us confidence in the accuracy of our conclusion that potassium supplementation had no beneficial effect on blood pressure in this normotensive population.
The results of the present study should not be extrapolated to other racial groups, hypertensive patients, elderly patients, or to studies of potassium in combination with other anions. One should be particularly cautious regarding implications for the black population, for which studies have shown significant differences in potassium balance in both adults 3 * and children. 37 Future studies of potassium supplementation and blood pressure might be better directed toward high risk subjects of the normotensive population, to those with reduced dietary potassium intake, and to hypertensive subjects.
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